![David Lee: Best part of ASCO breakthrough 2024](https://oncodaily.com/pub/uploads/2024/08/GUqceadaUAEi8yp-1280x720.jpeg)
Photo from David Lee/X
Aug 12, 2024, 22:09
David Lee: Best part of ASCO breakthrough 2024
David Lee shared on X:
“Best part of ASCO breakthrough 2024 – meet old friends and make new ones. Love this bunch of smart, genuine and fun people. A great platform to unite us.”
Source: David Lee/X
Dr. David Lee Dai Wee is a Consultant Clinical Oncologist at the University of Malaya Medical Centre and a lecturer at the Faculty of Medicine, University of Malaya.
He is the principal investigator for multiple international multicenter clinical trials, specializing in early-phase studies, thoracic cancers, and head and neck cancers.
Dr. Lee received the ASCO Leadership Development Program – Asia Pacific award in 2021-2022 and the ASCO International Development and Education Award (IDEA) in 2024, as well as the IASLC Academy Award in 2024.